TMED2 and ovarian carcinoma: In contrast, elevated levels of TMED2 were found in ovarian carcinoma patients (Shi-peng et al., 2017), and ectopic expression of TMED2 in ovarian cancer cells resulted in increased cell proliferation and cell migration, characteristic of metastatic cells.